Live Stock Performance

About the Company

May & Baker Nigeria PLC, established on September 4, 1944, is Nigeria’s first pharmaceutical company. The company operates under two major business units: the Pharmaceutical Manufacturing Business and the Beverages Business. It has four subsidiaries: Biovaccines Nigeria Limited, Osworth Nigeria Limited, Servisure Nigeria Limited, and Tydipacks Nigeria Limited. May & Baker Nigeria PLC is committed to supporting health for life by providing a wide range of pharmaceutical products, including anti-diabetics, anti-infectives, anti-malaria, analgesics, cough and cold treatments, multivitamins, and anxiolytics.

Leadership Team

• Mr. Nnamdi Okafor – Managing Director/CEO
• Mr. Ayodeji Aboderin – Chief Financial Officer
• Mr. Chidi Okoro – Executive Director, Sales & Marketing
• Mr. Emmanuel Ekunno – Executive Director, Operations

Corporate Social Responsibility (CSR)

May & Baker Nigeria PLC is committed to corporate social responsibility through initiatives that promote health, education, and community development. The company supports various programs aimed at improving the quality of life in its host communities, emphasizing responsible business practices and social impact.

Company Milestones

• 1944: Established as Nigeria’s first pharmaceutical company.
• 1976: Built its factory at Ikeja, Lagos State, and began local manufacturing of pharmaceuticals.
• 1994: Became a publicly quoted company following its listing on the Nigerian Stock Exchange on November 10.
• 2011: Completed and commissioned a World Health Organization Standard Pharmaceutical production facility on June 27.